MENU
PRLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Prelude Therapeutics (PRLD) Ownership - Who owns Prelude Therapeutics?
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs... Show more
Profile
Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
128
Web
https://www.preludetx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
37.44M
P/E Ratio
N/A
Total Cash
133.61M
Projected Growth
N/A
Total Debt
18.03M
Revenue
7M
Risk (Beta)
1.46
Dividend Yield
N/A
Total Cash/Share
2.42
Total Debt/Equity
N/A
Revenue/Share
0.09 USD as % of share price
Fundamentals
PRLD
Capitalization
37.4M
P/E Ratio
N/A
Risk (Beta)
1.46
Dividend Yield
N/A
Total Cash
134M
Total Cash/Share
2.42
Total Debt
18M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.09%
Revenue
7M
ROE
N/A
Book Value
131M
P/B Ratio
0.28
Cash Flow
N/A
Earnings
-1.68
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
5.30
Current Revenue Per Employee
30534.35
Dividends Per Share - Security
N/A
EBITDA
-137.94M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-56.12
Shares Held By Institutions
47.2M
Shares Outstanding - Current
55.2M
Total Liabilities
44.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-47.059
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
128
Web
https://www.preludetx.com